Third generation oral contraceptives (OCs) are apparently stronger risk factors for venous
thromboembolism (VTE) than other OCs, however, the increased risk may be due to …

Kannel WB (Framingham Heart Study of the National Heart, Lung and Blood Institute,
Framingham, MA, USA). Oral contraceptive hypertension and thromboembolism. Int J …

Combined oral contraceptives (OC) are known to increase the risk of venous
thromboembolism. The aim of this randomized, cycle-controlled, cross-over study in 28 …

The relationship between oral contraceptive usage and thromboembolism is controversial.
Since thromboembolism is often undiagnosed, both clinically and at routine autopsy, most …

BACKGROUND: Combined oral contraceptives (COC) increase the risk of venous
thromboembolism (VTE), but the risk of recurrent VTE is not precisely determined. In this …

Despite the improvement and widespread use of hormonal contraceptives, both one of the
most reliable methods of contraception and a treatment for many gynecological diseases …

The G20210A prothrombin mutation, associated with elevated prothrombin levels, is a risk
factor for venous thromboembolism (VTE) and displays a strong interaction with oral …

The results of three independent studies of venous thromboembolic disease (VTE) and oral
contraceptives are reviewed together with two further cohort/case-control studies which we …

We studied 67 healthy women who were randomly allocated to receive third generation
gestodene (Gynera®) or second generation levonorgestrel (Microgynon 30®) combina tion …

The use of oral contraceptives (OC) causes disturbances of the procoagulant, anticoagulant
and fibrinolytic pathways of blood coagulation which may contribute to the increased risk of …